[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:borderline-personality-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":85,"states":86},"Borderline Personality Disorder",12,10,[8,16,23,29,35,41,47,53,59,65,71,78],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06446765","Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder",[12],"Phase 2","RECRUITING","2026-08-26T02:19:02.550788Z","2026-07-05T05:32:16.752748Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07460947","A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder",[20],"Phase 1\u002FPhase 2","2026-08-26T02:15:33.331531Z","2026-05-05T02:43:28.731402Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06772831","Cognitive Reappraisal Training for Borderline Personality (BPD)",[],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:27.593929Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07197502","Treatment of Borderline Personality Disorder With rTMS",[],"2026-08-26T02:15:04.877798Z","2026-05-05T02:43:27.279696Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05651295","A Precision Medicine Approach to Target Engagement for Emotion Regulation",[],"2026-08-26T02:17:02.694423Z","2026-05-13T02:55:06.367187Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT04296604","Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations",[],"2026-08-26T02:18:44.395098Z","2026-05-05T02:43:28.886759Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT05712057","Neurostimulation Versus Therapy for Problems With Emotions",[],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:28.641496Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT05800925","Triage Survey for Psychiatry Research Eligibility",[],"2026-08-26T02:15:34.659160Z","2026-05-29T15:36:40.166678Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT06880640","Affect-based Impulsivity in Borderline Personality Disorder",[],"2026-08-26T02:15:11.740957Z","2026-05-05T02:43:29.470345Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT06683014","MDMA in Borderline Personality Disorder",[12],"2026-08-26T02:18:14.396999Z","2026-05-05T02:43:28.534638Z",{"nct_id":72,"title":73,"phases":74,"status":75,"updated_at":76,"content_modified":77},"NCT05989529","Delving Into Borderline Personality Disorder Clinical Trial Experiences",[],"NOT_YET_RECRUITING","2026-08-26T02:17:54.420226Z","2026-05-13T02:55:06.398605Z",{"nct_id":79,"title":80,"phases":81,"status":82,"updated_at":83,"content_modified":84},"NCT06045650","Relationship Between Oxytocin Level, Trust, and Attachment in Individuals With Borderline Personality Disorder",[],"UNKNOWN","2026-08-03T02:06:20.225302Z","2026-05-13T02:55:06.405023Z",[],[87,91],{"state":88,"count":89,"slug":90},"Massachusetts",3,"massachusetts",{"state":92,"count":89,"slug":93},"New York","new-york"]